Surgery Partners Seeks Bondholder Consent Ahead of Planned Merger

Surgery Center Holdings, a Surgery Partners subsidiary, began soliciting consents from investors in its $1.225B of 7.250% senior notes due 2032 for indenture changes tied to the planned merger with Spyglass Topco. The amendments would prevent the transaction from triggering a Change of Control repurchase obligation and would take effect immediately before closing, which is expected in Q1 2027 if required approvals are obtained. Consenting holders may receive $2.50 per $1,000 of principal, and approval requires support from owners of more than half of the notes outstanding.

Without the amendments, the issuer would have to offer to buy back the notes at 101% of principal plus accrued interest. The solicitation gives eligible bondholders a cash incentive to approve changes that preserve the existing notes through the merger, while the transaction remains subject to stockholder, regulatory and other closing conditions.

  • 1The notes carry a 7.250% interest rate and mature in 2032, with $1.225B outstanding.
  • 2Consenting noteholders may receive $2.50 for each $1,000 of principal amount.
  • 3Absent the proposed changes, the merger would require an offer to repurchase the notes at 101% of principal plus accrued interest.
  • 4The consent process requires approval from noteholders representing more than half of the outstanding principal.
  • 5The merger is expected to close in Q1 2027, subject to stockholder, regulatory and other customary approvals.

Sources